None listed
Conditions
Interventions
Others : After the randomization, study subjects in intervention group should use a smartphone application that was invented for this study. They can download the application on the web. The subjects
Sponsors
Seoul National University Bundang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with atrial fibrillation with edoxaban treatment for stroke prevention 2. Age equal or greater than 19 years-old 3. Capable of use smart-phone application 4. Accepted for the study protocol and willing to participate the clinical study
Exclusion criteria
Exclusion criteria: 1. Creatinine clearance less than 15 mL/min/1.73m2 2. Patients with dual antiplatelet therapy 3. More than moderate mitral stenosis 4. Previous history of mitral valve replacement or mitral valve repair 5. Previous history of alcohol or drug abuse 6. Not suitable for the clinical trial enrollment by the judgement of investigator 7. History of previous enrollment of other clinical trial using investigational pharmaceutical product 8. Patient is not willing to participate the clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adherence by pill count ([The number of pills should be taken - Number of missed pills]/ total number of pills should be taken during the period);adequate medication adherence, which was defined as =95% of continuous medication adherence | — |
Secondary
| Measure | Time frame |
|---|---|
| Stroke;systemic embolic event;major bleeding requiring hospitalization or transfusion;clinical composite endpoints, including stroke, systemic embolic events, major bleeding requiring hospitalization or transfusion, and death | — |
Countries
Korea, Republic of
Contacts
Public ContactJi Hyun Lee
Seoul National University Bundang Hospital
Outcome results
None listed